Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Clorox Co Stock Research

CLX

131.06USD+2.44(+1.90%)Market Closed
Watchlist

Market Summary

USD131.06+2.44
Market Closed
1.90%

CLX Alerts

  • Big jump in Earnings (Y/Y)

CLX Stock Price

CLX RSI Chart

CLX Valuation

Market Cap

16.2B

Price/Earnings (Trailing)

108.91

Price/Sales (Trailing)

2.2

EV/EBITDA

28.12

Price/Free Cashflow

17.45

CLX Price/Sales (Trailing)

CLX Profitability

EBT Margin

1.81%

Return on Equity

2.5K%

Return on Assets

1.27%

Free Cashflow Yield

5.73%

CLX Fundamentals

CLX Revenue

Revenue (TTM)

7.4B

Revenue Y/Y

12.1%

Revenue Q/Q

5.43%

CLX Earnings

Earnings (TTM)

149.0M

Earnings Y/Y

74.26%

Earnings Q/Q

183.41%

Price Action

52 Week Range

123.52178.21
(Low)(High)

Last 7 days

-1.2%

Last 30 days

-16.5%

Last 90 days

-17.6%

Trailing 12 Months

-0.7%

CLX Financial Health

Current Ratio

0.87

CLX Investor Care

Dividend Yield

3.6%

Dividend/Share (TTM)

4.72

Shares Dilution (1Y)

0.54%

Diluted EPS (TTM)

1.2

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for CLX

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-09-13
Grier Stacey
sold (taxes)
-13,408
147
-91.00
evp - chief growth & str ofc
2023-09-13
Reynolds Eric H
sold (taxes)
-44,647
147
-303
evp - chief operating officer
2023-09-13
Jacobsen Kevin B
acquired
659,686
147
4,477
evp - chief financial officer
2023-09-13
Grier Stacey
acquired
232,518
147
1,578
evp - chief growth & str ofc
2023-09-13
Reynolds Eric H
acquired
813,814
147
5,523
evp - chief operating officer
2023-09-13
Marriner Kirsten
sold (taxes)
-167,537
147
-1,137
evp - chief people officer
2023-09-13
Rendle Linda J
acquired
1,937,950
147
13,152
chief executive officer
2023-09-13
Hilt Angela C
acquired
294,847
147
2,001
evp - chief legal officer
2023-09-13
Peck Laurene E
acquired
13,556
147
92.00
vp - cao & corp controller
2023-09-13
Marriner Kirsten
acquired
465,037
147
3,156
evp - chief people officer

1–10 of 50

Which funds bought or sold CLX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-26
BROOKFIELD Corp /ON/
new
-
6,043,680
6,043,680
0.02%
2023-09-26
M Holdings Securities, Inc.
sold off
-100
-1,211,000
-
-%
2023-09-21
Baystate Wealth Management LLC
added
0.4
1,182
118,769
0.01%
2023-09-20
BARCLAYS PLC
added
22.48
6,659,000
35,490,000
0.02%
2023-09-19
BIRMINGHAM CAPITAL MANAGEMENT CO INC/AL
reduced
-1.76
-17,023
1,334,530
0.56%
2023-09-12
Farther Finance Advisors, LLC
added
670
533,184
612,304
0.13%
2023-09-08
TUCKER ASSET MANAGEMENT LLC
added
487
286,567
344,958
0.10%
2023-09-07
ST GERMAIN D J CO INC
new
-
637,591
637,591
0.03%
2023-09-05
Delos Wealth Advisors, LLC
unchanged
-
13.00
2,704
-%
2023-08-29
Garde Capital, Inc.
new
-
573,000
573,000
0.05%

1–10 of 48

Latest Funds Activity

Are funds buying CLX calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CLX
No. of Funds

Schedule 13G FIlings of Clorox

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2023
vanguard group inc
12.28%
15,151,580
SC 13G/A
Feb 06, 2023
state street corp
7.17%
8,844,196
SC 13G/A
Jan 31, 2023
blackrock inc.
7.5%
9,267,422
SC 13G/A
Feb 14, 2022
state street corp
6.71%
8,240,920
SC 13G/A
Feb 09, 2022
vanguard group inc
11.80%
14,500,034
SC 13G/A
Feb 01, 2022
blackrock inc.
8.8%
10,774,842
SC 13G/A
Feb 12, 2021
state street corp
5.89%
7,426,780
SC 13G
Feb 10, 2021
vanguard group inc
12.15%
15,320,366
SC 13G/A
Jan 29, 2021
blackrock inc.
9.5%
11,966,765
SC 13G/A
Feb 14, 2020
state street corp
6.74%
8,463,983
SC 13G

Recent SEC filings of Clorox

View All Filings
Date Filed Form Type Document
Sep 18, 2023
8-K
Current Report
Sep 15, 2023
4
Insider Trading
Sep 15, 2023
4
Insider Trading
Sep 15, 2023
4
Insider Trading
Sep 15, 2023
4
Insider Trading
Sep 15, 2023
4
Insider Trading
Sep 15, 2023
4
Insider Trading
Sep 15, 2023
4
Insider Trading
Aug 24, 2023
4
Insider Trading
Aug 16, 2023
4
Insider Trading

Peers (Alternatives to Clorox)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
357.9B
82.0B
-5.31% 14.14%
25.07
4.46
2.27% -0.60%
63.2B
18.7B
-3.71% -0.27%
35.42
3.52
5.51% -22.99%
48.5B
20.4B
-6.65% 5.11%
24.55
2.39
1.47% -8.06%
22.4B
-
-4.56% 26.10%
50.24
75.72
-94.06% -42.72%
16.2B
7.4B
-16.55% -0.72%
108.91
2.2
3.97% -67.75%
MID-CAP
9.4B
5.6B
-5.02% 70.61%
18.41
1.68
4.71% 95.84%
6.0B
672.6M
-19.65% 192.49%
59.74
8.89
61.02% 257.75%
5.4B
3.9B
-6.56% -1.56%
22.71
1.39
4.88% -13.50%
3.2B
2.9B
-6.49% 100.14%
1.76
1.08
-6.79% 1581.68%
2.8B
527.2M
-6.26% 13.96%
42.95
5.23
4.68% 5.34%
2.3B
2.9B
-8.90% 28.46%
-9.46
0.78
-2.87% -212.81%
SMALL-CAP
316.5M
432.4M
5.21% 99.40%
47.52
0.73
-3.33% -61.91%
34.6M
10.4M
-0.92% -35.14%
15.43
3.33
-27.57% -39.04%

Clorox News

MarketBeat
Q2 2024 EPS Estimates for The Clorox Company Cut by Analyst ....
MarketBeat,
3 hours ago
GuruFocus.com
Investing.com Australia
The Clorox Company

Returns for CLX

Cumulative Returns on CLX

7.4%


10-Year Cumulative Returns

3.0%


7-Year Cumulative Returns

-0.5%


5-Year Cumulative Returns

-12.9%


3-Year Cumulative Returns

Risks for CLX

What is the probability of a big loss on CLX?

49.2%


Probability that Clorox stock will be more than 20% underwater in next one year

13.8%


Probability that Clorox stock will be more than 30% underwater in next one year.

0%


Probability that Clorox stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CLX drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Clorox was unfortunately bought at previous high price.

Drawdowns

Financials for Clorox

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue3.0%7,3897,1717,0657,0417,1077,1087,0807,2317,3417,5227,5247,1316,7216,3656,1336,1576,2146,2786,2446,1876,124
Gross Profit7.1%2,9082,7142,5632,5012,5452,5452,6702,9493,1993,4603,5183,3203,0632,8682,7092,7132,7282,7382,7142,6802,675
  S&GA Expenses7.7%1,1831,0981,0209799549709741,0021,0041,0231,055996969907854855856867859845837
  R&D Expenses3.0%138134130131132143144150149146153147145141136134136135133132132
EBITDA-100.0%-4679068669378946358731,2101,4971,8441,7391,4641,3611,304------
EBITDA Margin-100.0%-0.07*0.13*0.12*0.13*0.13*0.09*0.12*0.16*0.20*0.25*0.24*0.22*0.21*0.21*------
Interest Expenses-15.1%90.0010610310310694.0098.0099.0099.0099.0098.0099.0099.0099.0099.0098.0097.0096.0092.0088.0085.00
Earnings Before Taxes83.1%2381305755386075793205599001,1941,5501,4531,1851,0821,0251,0141,0241,0381,0401,0431,054
EBT Margin-100.0%-0.02*0.08*0.08*0.09*0.08*0.05*0.08*0.12*0.16*0.21*0.20*0.18*0.17*0.17*------
Net Income101.4%14974.004354054624582474377109231,2251,151939870816813820796790841823
Net Income Margin-100.0%-0.01*0.06*0.06*0.07*0.06*0.03*0.06*0.10*0.12*0.16*0.16*0.14*0.14*0.13*------
Free Cashflow-100.0%-8407216785355635806209451,3051,3831,3891,292966810------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets2.2%5,9455,8186,0456,1536,1586,3226,1906,2746,3346,4416,8556,7776,2135,8505,4595,3975,1165,1625,0735,0585,060
  Current Assets4.8%1,8281,7451,6221,7631,7251,8691,7411,8201,8291,9622,1032,1442,0201,7501,3031,2661,3051,3931,3651,3171,311
    Cash Equivalents51.7%367242168278183243196214324497737867879505174157113180165165134
  Inventory-5.3%696735741755755803818785752688609534454457514504512556578519506
  Net PPE2.3%1,3451,3151,3221,3221,3341,3121,2981,3011,3021,2511,2211,1761,1031,0471,0521,0341,0341,000992988996
  Goodwill0.2%1,2521,2501,5531,5471,5581,5721,5651,5661,5751,5741,8031,7932081,5681,5881,5851,5911,5891,5861,6021,602
Liabilities-1.6%5,5575,6465,5545,6575,4295,7465,6995,7275,7425,5035,4755,4665,3055,1554,9044,8474,5574,3814,3314,3814,334
  Current Liabilities-4.0%1,9171,9961,8782,0101,7842,6432,5962,6392,0561,8191,7381,5161,4181,7941,5131,4581,4401,2611,1861,2351,200
    LT Debt, Current------600600899300300300----------
    LT Debt, Non Current0.0%2,4772,4762,4762,4752,4741,8871,8861,8852,4842,4832,4832,7812,7802,2882,2882,2872,2872,2862,2852,2852,284
Shareholder's Equity7233.3%2203.004914965565764915475929381,3801,311908695555550559781742677726
  Retained Earnings40.5%5834157828321,0489519491,0271,0361,0861,3023,8403,5673,3983,2923,2413,1503,0042,9402,8832,797
  Additional Paid-In Capital1.1%1,2451,2321,2071,1931,2021,1951,1801,1661,1861,1901,1761,1461,1371,1111,0621,0431,0461,0331,014984975
Accumulated Depreciation-100.0%-2,6722,6212,5752,5302,5102,4662,4222,3822,3512,3192,2702,2242,2032,1852,1562,1502,1252,1092,0842,061
Shares Outstanding0.2%124124123123123123123123123126126126126126125126126128128128128
Minority Interest-0.6%168169170170173176178179181195196196---------
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations8.9%1,1581,0639519237868348699341,2761,6331,6771,6581,5461,1951,0411,0049921,0031,101975976
  Share Based Compensation7.4%73.0068.0058.0053.0052.0042.0040.0046.0050.0065.0066.0057.0050.0046.0044.0041.0043.0050.0048.0049.0053.00
Cashflow From Investing-9.3%-223-204-204-218-229-278-306-357-452-448-412-361-252-215-217-202-196-873-862-859-859
Cashflow From Financing11.6%-753-852-769-632-689-810-1,102-1,236-1,391-1,206-709-587-523-647-815-806-815-1,120-560-415-399
  Dividend Payments0.5%583580577574571566563560558554547540533521511501490492478464450
  Buy Backs-----25.00325630830905628353238248571613568661516444408271

CLX Income Statement

2023-06-30
CONSOLIDATED STATEMENTS OF EARNINGS - USD ($)
shares in Thousands, $ in Millions
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]   
Net sales$ 7,389$ 7,107$ 7,341
Cost of products sold4,4814,5624,142
Gross profit2,9082,5453,199
Selling and administrative expenses1,1839541,004
Advertising costs734709790
Research and development costs138132149
Goodwill, trademark and other asset impairments4450329
Interest expense9010699
Other (income) expense, net8037(72)
Earnings (losses) before income taxes238607900
Income taxes77136181
Net earnings161471719
Less: Net earnings attributable to noncontrolling interests1299
Net earnings attributable to Clorox$ 149$ 462$ 710
Net earnings per share attributable to Clorox   
Basic net earnings per share (in dollars per share)$ 1.21$ 3.75$ 5.66
Diluted net earnings per share (in dollars per share)$ 1.20$ 3.73$ 5.58
Weighted average shares outstanding (in thousands)   
Basic (in shares)123,589123,113125,570
Diluted (in shares)124,181123,906127,299

CLX Balance Sheet

2023-06-30
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jun. 30, 2023
Jun. 30, 2022
Current assets  
Cash and cash equivalents$ 367$ 183
Receivables, net688681
Inventories, net696755
Prepaid expenses and other current assets77106
Total current assets1,8281,725
Property, plant and equipment, net1,3451,334
Operating lease right-of-use assets346342
Goodwill1,2521,558
Trademarks, net543687
Other intangible assets, net169197
Other assets462315
Total assets5,9456,158
Current liabilities  
Notes and loans payable50237
Current operating lease liabilities8778
Accounts payable and accrued liabilities1,6591,469
Income taxes payable1210
Total current liabilities1,9171,784
Long-term debt2,4772,474
Long-term operating lease liabilities310314
Other liabilities825791
Deferred income taxes2866
Total liabilities5,5575,429
Commitments and contingencies
Stockholders’ equity  
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding00
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of June 30, 2023 and 2022; and 123,820,022 and 123,152,132 shares outstanding as of June 30, 2023 and 2022, respectively131131
Additional paid-in capital1,2451,202
Retained earnings5831,048
Treasury stock, at cost: 6,921,439 and 7,589,329 shares as of June 30, 2023 and 2022, respectively(1,246)(1,346)
Accumulated other comprehensive net (loss) income(493)(479)
Total Clorox stockholders’ equity220556
Noncontrolling interests168173
Total stockholders’ equity388729
Total liabilities and stockholders’ equity$ 5,945$ 6,158
Linda Rendle
9000
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brand names; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brand names; professional food service products under the Hidden Valley brand name; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brand names in the United States. The Household segment provides cat litter products under the Fresh Step, Scoop Away, and Ever Clean brand names; bags and wraps under the Glad brand name; and grilling products under the Kingsford and Kingsford Match Light brand names in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand name; natural personal care products under the Burt's Bees brand name; and water-filtration systems and filters under the Brita brand name in the United States. The International segment provides laundry additives; home care products; water-filtration systems and filters; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brand names. The Clorox Company sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, third-party and owned e-commerce channels, military stores, and distributors, as well as a direct sales force. The company was founded in 1913 and is headquartered in Oakland, California.